CC-359

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCC-359
Drug Alias NameCC-359JNK-9359JNK-359
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase inhibitors
Targetsc-Jun N-terminal kinase
Therapy Area/IndicationsNerve DegenerationFibrosisDiabetes Mellitus +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene Corp
Active IndicationsN/A
Inactive IndicationsNerve DegenerationFibrosisDiabetes Mellitus +[7] 

Other Information

ATC CodeN/A
Related LinksN/A